Greenwich Lifesciences earnings were -$15.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest GLSI earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$8.0M, up 201.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GLSI reported annual earnings of -$15.8M, with 77.6% growth. The next GLSI earnings date is May 19, 2025.
Greenwich Lifesciences Earnings Reports & History FAQ
What were Greenwich Lifesciences's earnings last quarter?
Greenwich Lifesciences (NASDAQ: GLSI) reported Q4 2024 earnings per share (EPS) of -$0.61, up 190.48% year over year. Total GLSI earnings for the quarter were -$8.04 million. In the same quarter last year, Greenwich Lifesciences's earnings per share (EPS) was -$0.21.
The next GLSI earnings date is Invalid Date. Add GLSI to your watchlist to be reminded of Greenwich Lifesciences's next earnings date.
What was GLSI's earnings growth in the past year?
As of Greenwich Lifesciences's earnings date in Q2 2025, Greenwich Lifesciences's earnings has grown year over year. GLSI earnings in the past year totalled -$15.79 million.
Is Greenwich Lifesciences profitable or losing money?
As of the last Greenwich Lifesciences earnings report, Greenwich Lifesciences is currently losing money. Greenwich Lifesciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$15.79 million, a 77.57% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.